Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581227 · ClinicalTrials.gov registry record
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 4,679
- Enrollment target
NCT03581227 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 4,679 participants.
The verdict
NCT03581227 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 4,679 participants
- Enrollment target
Study Summary
A prospective multi-center study to define the sensitivity and specificity of CAPTURE for identifying previously undiagnosed patients with clinically significant COPD in a broad range of primary care settings.
Interventions
- OTHER CAPTURE Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,679 participants |
| Start Date | 2018-10-12 |
| Est. Completion | 2022-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03581227
The ClinicalTrials.gov registry entry for NCT03581227 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,679 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CAPTURE Tool is the first listed.
NCT03581227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03581227 about?
NCT03581227 is a clinical study titled "The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)". A prospective multi-center study to define the sensitivity and specificity of CAPTURE for identifying previously undiagnosed patients with clinically significant COPD in a broad range of primary care settings.
What is the current status of trial NCT03581227?
This trial is currently completed. The enrollment target is 4,679 participants. The study started on 2018-10-12. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT03581227?
The interventions under investigation include: CAPTURE Tool (OTHER).
Who is sponsoring clinical trial NCT03581227?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.